ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1356	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	general cancer information 0.411851 treatment 0.656267 cancer treatment 0.493001 breast cancer cells 0.486603 primary cancer 0.600191 new cancer treatments 0.408458 Peritoneal Cancer Treatment 0.426103 cancer cells 0.712358 tissue 0.443805 malignant tumor cells 0.423112 body 0.560831 type 0.447878 Cancer Information Service 0.414189 Squamous Neck Cancer 0.400297 PDQ cancer information 0.512966 clinical trial search 0.39505 treatment clinical trials 0.437756 certain changes 0.407705 National Cancer Institute 0.54586 clinical trials 0.823063 normal cells 0.410928 cancer information summary 0.471688 clinical trial 0.588388 new treatment 0.44726	breast cancer prevention 0.400005 primary cancer site 0.517081 cancer tissue 0.403216 patients 0.429603 Cancer Care page 0.397493 PDQ summary 0.435669 treatment clinical trial 0.401935 PDQ Adult Treatment 0.398071 NCI PDQ cancer 0.432436 cancer research process 0.400715 cancer clinical trials 0.44656 tests 0.388491 lymph nodes 0.409196 Unknown Primary Treatment 0.395812 carcinoma 0.39749 primary cancer depend 0.439856 lymph node 0.431668 radiation therapy 0.485838 Treatment Editorial Board 0.413559 cancer information summaries 0.411898 comprehensive cancer information 0.411754 cancer 0.945761 standard treatment 0.426236	CLICK HERE
1474	National Cancer Institute	Html	en	Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Health Professional Version	Bile duct cancer (also called cholangiocarcinoma) can occur in the bile ducts in the liver (intrahepatic) or outside the liver (perihilar or distal extrahepatic). Learn about the types of bile duct cancer, risk factors, clinical features, staging, and treatment for bile duct cancer in this expert-reviewed summary.	additional pathologic features. 0.343846 primary liver tumors. 0.348145 bile ducts 0.444712 bile duct cancer 0.774651 bile duct stents 0.508992 hepatic duct bifurcation 0.404346 PDQ cancer information 0.373495 percutaneous techniques. 0.346185 perihilar bile duct 0.511799 proximal sites. 0.347462 hepatic parenchymal involvement 0.388752 periampullary cancers 0.343456 adjacent lymph nodes 0.354705 Total resection 0.360577 bile duct 0.91687 biliary obstruction 0.349692 cancer information summary 0.370218 distal common bile 0.433923 breast cancer prevention 0.344027 bile duct cancers 0.460438 prognostic significance 0.344453 Complete surgical resection 0.356029 NCI PDQ cancer 0.348518 lymph nodes 0.407313 chemoradiation therapy 0.374933	negative surgical margins 0.381244 resectability rate 0.342032 distal bile duct 0.520391 hematogenous hepatic metastases 0.357094 bile duct tumor 0.499985 distal extrahepatic bile 0.469165 surgical resection 0.358613 extrahepatic bile duct 0.560834 Palliative therapy 0.345322 common bile duct 0.519545 distal extrahepatic tumors 0.38772 adjacent bile ducts 0.413158 intrahepatic tumors 0.365671 small randomized trial 0.379708 regional lymph node 0.345414 major blood vessels 0.472926 extrahepatic biliary tract 0.368664 aggressive surgical approach 0.342191 bile duct resection 0.486545 primary tumor extent 0.350795 lymph node involvement 0.3862 hepatic dysfunction 0.353326 bile duct tumors 0.574769 biliary tree 0.346954	CLICK HERE
1512	National Cancer Institute	Html	en	Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of osteosarcoma/malignant fibrous histiocytoma of bone.	cancer treatment 0.407081 malignant tumor cells 0.349447 body 0.457542 type 0.332048 chemotherapy 0.334597 PDQ cancer information 0.39878 clinical trial search 0.334862 clinical trials 0.824706 Pediatric Treatment Editorial 0.299208 cancer information summary 0.360916 clinical trial 0.498576 kinase inhibitor therapy 0.337105 detailed pictures 0.314561 patients 0.324824 NCI PDQ cancer 0.313063 radiation therapy 0.384486 Treatment Editorial Board 0.303904 bone cancer 0.343085 treatment 0.712766 wide local excision 0.303347 magnetic resonance imaging 0.301911 new cancer treatments 0.298777 osteosarcoma cells 0.305575 NCI-supported cancer 0.30089	cancer cells 0.508672 standard treatment 0.304104 Cancer Information Service 0.301597 MFH 0.338322 specific cancer cells 0.314742 Recurrent osteosarcoma 0.349728 patient 0.335989 treatment clinical trials 0.338171 National Cancer Institute 0.390929 effects cancer treatment 0.325995 new treatment 0.35734 treatment clinical trial 0.302675 bone 0.549956 primary tumor 0.351503 nuclear magnetic resonance 0.304246 PDQ summary 0.321698 cancer clinical trials 0.368405 Combination chemotherapy 0.30296 tumor 0.52585 cancer information summaries 0.299038 comprehensive cancer information 0.299274 cancer 0.934486 osteosarcoma 0.560059 surgery 0.417923	CLICK HERE
1765	National Cancer Institute	Html	en	Physical Activity and Cancer	A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks.	U. Physical activity 0.367372 bone-strengthening physical activity 0.370971 physical activity daily 0.371076 physical activity attenuate 0.362897 better breast cancer 0.3594 low physical activity 0.37763 Breast Cancer Research 0.357155 muscle-strengthening physical activity 0.370998 vigorous physical activity 0.364437 S. Physical activity 0.365821 average breast cancer 0.365315 cancer risk reduction 0.373439 colorectal cancer 0.41572 average endometrial cancer 0.357301 H. Physical activity 0.366033 postdiagnosis physical activity 0.363749 postmenopausal breast cancer 0.379275 lower risk 0.357009 potential physical activity 0.369413 physical activity influence 0.360893 different cancer risk 0.360424 aerobic physical activity 0.386234 vigorous-intensity physical activity 0.373987 cancer survivors 0.406644 Cancer Epidemiology 0.363652	cancer prevention 0.376861 Physical Activity website 0.371276 A. Physical activity 0.364619 breast cancer diagnosis 0.4205 endometrial cancer risk 0.390992 breast cancer recurrence 0.359315 Physical Activity Guidelines 0.371598 links physical activity 0.369787 physical activity benefit 0.375758 National Cancer Institute 0.363045 daily physical activity 0.370902 L. Physical activity 0.366831 breast cancer risk 0.390634 colon cancer 0.375643 meta-analysis 0.376142 breast cancer 0.54813 colon cancer risk 0.372667 systematic review 0.435657 physical activity 0.996162 prostate cancer 0.369869 leisure-time physical activity 0.442557 et al 0.539243 cancer risk 0.441434 recreational physical activity 0.391568	CLICK HERE
1979	National Cancer Institute	Html	es	Tratamiento del rabdomiosarcoma infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del rabdomiosarcoma infantil.	células madre 0.954525 siguientes áreas 0.355532 siguientes aspectos 0.345034 faja ajustadora 0.355343 Neurofibromatosis tipo 0.398703 pequeña cantidad 0.348929 tratamiento causa 0.401205 siguientes especialistas 0.350222 células normales.ampliar exploración 0.555609 siguientes tipos 0.375562 ganglio linfático centinela 0.774296 inhibidores mTOR 0.329972 vía oral 0.328502 rayos x 0.346885 enlace drugs approved 0.35022 niño ayuda 0.372159 células t 0.487208 riesgo intermedio 0.403207 efectos tardíos 0.595364 escáner.ampliar exploración 0.352033 PDQ Efectos tardíos 0.369328 cáncer.ampliar aspiración 0.354315 PD-1.Ampliar Inhibidor 0.337643	IRMN).Ampliar Imágenes 0.339532 quimioterapia cirugía 0.420931 siguientes grupos 0.353321 alta potencia 0.340546 inhibidor mTOR 0.336127 vidrio piezas 0.342053 explorador tep 0.355728 radiación causa 0.339533 partes distantes 0.5268 Physician Data Query 0.3272 siguientes sitios 0.353923 estadio i 0.352332 siguientes partes 0.360629 siguientes situaciones 0.359982 siguientes enfermedades 0.373061 simple vista 0.337921 rabdomiosarcoma infantil causa 0.550983 microscopio células 0.494661 panel derecho 0.369117 Ojos saltones 0.35339 grupos iia 0.338863 siguientes sumarios 0.39802 siguientes pruebas 0.374587	CLICK HERE
2068	National Cancer Institute	Html	es	Marcadores de tumores	Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer.	Bast RC Jr 0.727949 cancer screening 0.603977 Gray RJ 0.462067 randomized european study 0.51305 Asociación Estadounidense 0.468124 estudio plco 0.461327 Bigbee W 0.467579 amplia gama 0.464843 afecciones benignas 0.671952 Herberman RB 0.469893 Prevention Research 0.463207 BC Decker Inc 0.509079 Clinical Laboratory Improvement 0.519898 Cancer Screening Randomized 0.544857 Controlled Trial 0.467216 riesgo intermedio 0.462476 Clinical Practice 0.47196 ecografía transvaginal 0.471751 Makower DF 0.466396 estudio tailorx 0.460805 ¿Cuáles marcadores 0.637902 21-gene expression assay 0.514014	Hugosson J 0.463892 Instituto Nacional 0.461324 screening trial specimens 0.541412 Oncología Clínica 0.463202 tumor markers 0.619108 Andriole G 0.463781 Mortality results from 0.526447 Quality Requirements 0.470424 Kufe DW 0.468535 Black A 0.461077 6th ed 0.467056 Oncotype DX® 0.469566 situaciones benignas 0.492829 PubMed Abstract 0.928354 tratamientos resultantes 0.466203 Buys SS 0.460749 Bioquímica Clínica 0.461341 Pollock RE 0.46616 New England Journal 0.930005 Roobol MJ 0.466517 Sparano JA 0.466154 hoja informativa estadificación 0.539118	CLICK HERE
3566	National Cancer Institute	Html	en	Training	NCI offers training at laboratories and clinics in Maryland and at universities and institutions nationwide. These cancer training and career development opportunities cover a broad spectrum of disciplines for individuals at career stages ranging from high school and graduate students to scientists, clinicians, and health care professionals.	National Cancer Institute 0.966549		CLICK HERE
3582	National Cancer Institute	Html	en	Frederick National Laboratory for Cancer Research	The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS.	Frederick National Lab 0.679634 Development Center—one 0.586036 Federally Funded Research 0.723777 FNLCR 0.617129 biomarker identification 0.53533 animal sciences 0.53568 national resource 0.541398 government agencies 0.530109 human clinical trials 0.61809 preclinical assay development 0.712354 oncology-focused computational science 0.628628 cancer research laboratories 0.757218 early development 0.553877 research reagents 0.571396 NCI 0.666268 genetically engineered mouse 0.603734 preclinical research 0.638044 nonprofit research organizations 0.690454 broad charter 0.538883 Leidos Biomedical Research 0.735212 United States 0.647036 Nanotechnology Characterization Laboratory 0.625355 RAS family 0.527528 clinical practice 0.533965	NCI investigators 0.632716 significant cancer research 0.722685 translational genomics 0.544933 cancer research 0.952491 private sector business 0.653242 new drug development 0.647375 government sponsors 0.545164 biomedical research community 0.670235 development needs 0.584975 cancer researchers 0.562687 clinical operations 0.542191 Frederick National Laboratory 0.684108 government infrastructure 0.535486 technical staff 0.530406 preclinical model development 0.704349 private sector resources 0.635668 FNLCR programs 0.564698 National lab staff 0.628876 biomedical computing 0.548325 new cancer therapies 0.637914 frozen tumor samples 0.605424 nanotechnology applications 0.53469 cancer research enterprise 0.705608 basic research 0.59861	CLICK HERE
16886	National Cancer Institute	Html	en	Thyroid Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for thyroid cancer.	thyroid cancer trends 0.476323 thyroid tumors 0.422645 United States 0.468063 thyroid cancer screening. 0.46539 cancer registry data 0.363099 thyroid fine-needle aspiration 0.447959 opportunistic thyroid cancer 0.46743 thyroid cancer 0.931034 thyroid cancer incidence 0.631162 Thyroid Cancer Treatment 0.500772 Well-differentiated thyroid cancers 0.495048 palpation screening results 0.370878 total thyroidectomy 0.358528 cancer screening results 0.386186 radioactive iodine 0.350234 South Korea 0.456219 10-year relative survival 0.451331 frequently diagnosed cancer 0.37852 recurrent laryngeal nerve 0.36801 papillary thyroid cancer 0.525506 summary event measure 0.364067 free screening exams 0.364504 follicular thyroid cancers 0.495803 thyroid cancer mortality 0.490522	thyroid cancer overdiagnosis 0.479797 neck palpation 0.364787 cancer incidence rates 0.389027 thyroid cancer deaths. 0.489306 thyroid cancers cases 0.461202 thyroid cancer cases 0.467037 papillary thyroid cancers 0.524728 cancer diagnoses 0.354076 anaplastic thyroid cancers 0.495303 laryngeal nerve injury 0.368292 thyroid cancer screening 0.828908 thyroid cancers 0.597668 thyroid ultrasound 0.428817 suspicious screening result 0.361018 thyroid surgery 0.435882 population-based screening programs 0.366887 national cancer screening 0.412147 medullary thyroid cancer 0.491568 Cancer Screening Guidelines 0.39228 formal screening 0.347128 asymptomatic thyroid cancers 0.481523 incidental thyroid nodules 0.466527 vocal cord 0.353855	CLICK HERE
17244	National Cancer Institute	Html	en	2016 Outstanding Investigator Award Recipients	Learn how these investigators' projects aim to break new ground in biomedical, behavioral, and clinical cancer research.	new targets 0.616517 Family Comprehensive Cancer 0.63732 Cancer Society Professor 0.661378 telomere tumor suppressor 0.622203 human cancer cells 0.632309 Institution 0.684261 long-term research goal 0.623028 research 0.784162 cancer therapy 0.601965 American Cancer Society 0.727869 tumor tissue bank 0.611996 research program 0.776152 Harvard Medical School 0.721455 Sloan-Kettering Cancer Center 0.623471 new targeting strategies 0.599104 cell-inflamed tumor microenvironment 0.599952 Cancer Center 0.708997 human tumor antigen 0.611416 University Medical Center 0.60389 University Health Sciences 0.626966 Research Hospital Department 0.623587 Chief Scientific Officer 0.61003 PhD 0.607695 candidate cancer dependencies 0.602584 specific cancer contexts 0.610322	New York University 0.62278 cancer tumor growth 0.651904 mouse models 0.642277 Pediatric Oncology Research 0.601685 RAS tumor cells 0.626578 Society Research Professor 0.699783 Solove Research Institute 0.654164 Dana-Farber Cancer Institute 0.900346 Clinical Cancer Program 0.667087 Cancer Research 0.724099 Cancer Genetics Program 0.678263 new pathogenetic mechanisms 0.609043 new intervention approaches 0.604981 cancer susceptibility 0.603767 colon cancer 0.619759 Brain Tumor Center 0.607113 Title 0.668069 Comprehensive Cancer Center 0.68567 Cancer Society Research 0.723809 Cancer Hospital 0.60944 preventative cancer vaccines 0.648642 acute lymphoblastic leukemia 0.598837 tumor 0.657502 cancer biology 0.658172	CLICK HERE